spacer
spacer

PDBsum entry 1l4d
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase/hydrolase activator PDB id
1l4d

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
249 a.a. *
112 a.a. *
Ligands
SO4 ×2
Waters ×213
* Residue conservation analysis
PDB id:
1l4d
Name: Hydrolase/hydrolase activator
Title: Crystal structure of microplasminogen-streptokinase alpha domain complex
Structure: Plasminogen. Chain: a. Fragment: catalytic domain, residues 543-791. Engineered: yes. Mutation: yes. Streptokinase. Chain: b. Fragment: alpha domain, residues 14-147. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Streptococcus dysgalactiae subsp. Equisimilis. Organism_taxid: 119602. Strain: subsp. Equisimilis.
Biol. unit: Tetramer (from PQS)
Resolution:
2.30Å     R-factor:   0.206     R-free:   0.263
Authors: N.Wakeham,S.Terzyan,P.Zhai,J.A.Loy,J.Tang,X.C.Zhang
Key ref: N.Wakeham et al. (2002). Effects of deletion of streptokinase residues 48-59 on plasminogen activation. Protein Eng, 15, 753-761. PubMed id: 12456874
Date:
04-Mar-02     Release date:   11-Dec-02    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P00747  (PLMN_HUMAN) -  Plasminogen from Homo sapiens
Seq:
Struc: 		 
Seq:
Struc: 		810 a.a.
249 a.a.*
Protein chain
Pfam   ArchSchema ?
P00779  (STRP_STREQ) -  Streptokinase C from Streptococcus dysgalactiae subsp. equisimilis
Seq:
Struc: 		440 a.a.
112 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 2 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: Chain A: E.C.3.4.21.7  - plasmin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Preferential cleavage: Lys-|-Xaa > Arg-|-Xaa; higher selectivity than trypsin. Converts fibrin into soluble products.

 

 
Protein Eng 15:753-761 (2002)
PubMed id: 12456874  
 
 
Effects of deletion of streptokinase residues 48-59 on plasminogen activation.
N.Wakeham, S.Terzyan, P.Zhai, J.A.Loy, J.Tang, X.C.Zhang.
 
  ABSTRACT  
 
Streptokinase (SK) is a thrombolytic agent widely used for the clinical treatment of clotting disorders such as heart attack. The treatment is based on the ability of SK to bind plasminogen (Pg) or plasmin (Pm), forming complexes that proteolytically activate other Pg molecules to Pm, which carries out fibrinolysis. SK contains three major domains. The N-terminal domain, SKalpha, provides the complex with substrate recognition towards Pg. SKalpha contains a unique mobile loop, residues 45-70, absent in the corresponding domains of other bacterial Pg activators. To study the roles of this loop, we deleted 12 residues in this loop in both full-length SK and the SKalpha fragment. Kinetic data indicate that this loop participates in the recognition of substrate Pg, but does not function in the active site formation in the activator complex. Two crystal structures of the deletion mutant of SKalpha (SKalpha(delta)) complexed with the protease domain of Pg were determined. While the structure of SKalpha(delta) is essentially the same as this domain in full-length SK, the mode of SK-Pg interaction was however different from a previously observed structure. Even though mutagenesis studies indicated that the current complex represents a minor interacting form in solution, the binding to SKalpha(delta) triggered similar conformational changes in the Pg active site in both crystal forms.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
19473980 A.C.Tharp, M.Laha, P.Panizzi, M.W.Thompson, P.Fuentes-Prior, and P.E.Bock (2009).
Plasminogen substrate recognition by the streptokinase-plasminogen catalytic complex is facilitated by Arg253, Lys256, and Lys257 in the streptokinase beta-domain and kringle 5 of the substrate.
  J Biol Chem, 284, 19511-19521.  
19801674 R.Aneja, M.Datt, B.Singh, S.Kumar, and G.Sahni (2009).
Identification of a new exosite involved in catalytic turnover by the streptokinase-plasmin activator complex during human plasminogen activation.
  J Biol Chem, 284, 32642-32650.  
17111203 A.Kunamneni, T.T.Abdelghani, and P.Ellaiah (2007).
Streptokinase--the drug of choice for thrombolytic therapy.
  J Thromb Thrombolysis, 23, 9.  
15623524 R.R.Bean, I.M.Verhamme, and P.E.Bock (2005).
Role of the streptokinase alpha-domain in the interactions of streptokinase with plasminogen and plasmin.
  J Biol Chem, 280, 7504-7510.  
15211511 S.Terzyan, N.Wakeham, P.Zhai, K.Rodgers, and X.C.Zhang (2004).
Characterization of Lys-698-to-Met substitution in human plasminogen catalytic domain.
  Proteins, 56, 277-284.
PDB code: 1rjx
14732928 R.L.Rich, and D.G.Myszka (2003).
A survey of the year 2002 commercial optical biosensor literature.
  J Mol Recognit, 16, 351-382.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer
spacer